Solvonis Therapeutics plc (LON:SVNS)
London · Delayed Price · Currency is GBP · Price in GBX 0.1645
-0.0055 (-3.24%)
Jul 20, 2026, 3:38 PM GMT
Solvonis Therapeutics Market Cap
Solvonis Therapeutics has a market cap or net worth of 11.23 million as of July 20, 2026. Its market cap has decreased by -43.07% in one year.
Market Cap
11.23M
Enterprise Value
9.59M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.16
ChartMarket Cap Chart
Since January 6, 2022, Solvonis Therapeutics's market cap has decreased from 23.03M to 11.23M, a decrease of -51.24%. That is a compound annual growth rate of -14.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 11.23M | -46.77% |
| Dec 31, 2025 | 21.10M | 348.30% |
| Dec 31, 2024 | 4.71M | 686.33% |
| Dec 29, 2023 | 598.56K | -95.86% |
| Dec 30, 2022 | 14.47M | -37.18% |
| Jan 6, 2022 | 23.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Smiths Group | 7.59B |
| IMI plc | 7.04B |
| The Weir Group | 6.40B |
| Melrose Industries | 5.80B |
| Spirax Group | 5.14B |
| Rotork | 3.95B |
| Goodwin | 1.34B |
| Bodycote | 1.18B |